Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (11N3922N)
National Institutes of Health (R01-089897)
National Heart, Lung, and Blood Institute
National Jewish Health
AI in Flanders
Received: 16 June 2022
Accepted: 6 January 2023
First Online: 19 January 2023
: The institutional review boards of all participating centres approved the COPDGene study, and written informed consent was obtained from all subjects. The participating centres and its corresponding COPDGene investigators were:<i>Ann Arbor VA:</i> Jeffrey L. Curtis, MD; Perry G. Pernicano, MD.<i>Baylor College of Medicine, Houston, TX</i>: Nicola Hanania, MD, MS; Mustafa Atik, MD; Aladin Boriek, PhD; Kalpatha Guntupalli, MD; Elizabeth Guy, MD; Amit Parulekar, MD;<i>Brigham and Women’s Hospital, Boston, MA</i>: Dawn L. DeMeo, MD, MPH; Craig Hersh, MD, MPH; Francine L. Jacobson, MD, MPH; George Washko, MD.<i>Columbia University, New York, NY</i>: R. Graham Barr, MD, DrPH; John Austin, MD; Belinda D’Souza, MD; Byron Thomashow, MD.<i>Duke University Medical Center, Durham, NC</i>: Neil MacIntyre, Jr., MD; H. Page McAdams, MD; Lacey Washington, MD.<i>HealthPartners Research Institute, Minneapolis, MN</i>: Charlene McEvoy, MD, MPH; Joseph Tashjian, MD.<i>Johns Hopkins University, Baltimore, MD</i>: Robert Wise, MD; Robert Brown, MD; Nadia N. Hansel, MD, MPH; Karen Horton, MD; Allison Lambert, MD, MHS; Nirupama Putcha, MD, MHS.<i>Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA</i>: Richard Casaburi, PhD, MD; Alessandra Adami, PhD; Matthew Budoff, MD; Hans Fischer, MD; Janos Porszasz, MD, PhD; Harry Rossiter, PhD; William Stringer, MD.<i>Michael E. DeBakey VAMC, Houston</i>, <i>TX</i>: Amir Sharafkhaneh, MD, PhD; Charlie Lan, DO.<i>Minneapolis VA:</i> Christine Wendt, MD; Brian Bell, MD; Ken M. Kunisaki, MD, MS.<i>Morehouse School of Medicine, Atlanta, GA</i>: Eric L. Flenaugh, MD; Hirut Gebrekristos, PhD; Mario Ponce, MD; Silanath Terpenning, MD; Gloria Westney, MD, MS.<i>National Jewish Health, Denver, CO</i>: Russell Bowler, MD, PhD; David A. Lynch, MB.<i>Reliant Medical Group, Worcester, MA</i>: Richard Rosiello, MD; David Pace, MD.<i>Temple University, Philadelphia, PA:</i> Gerard Criner, MD; David Ciccolella, MD; Francis Cordova, MD; Chandra Dass, MD; Gilbert D’Alonzo, DO; Parag Desai, MD; Michael Jacobs, PharmD; Steven Kelsen, MD, PhD; Victor Kim, MD; A. James Mamary, MD; Nathaniel Marchetti, DO; Aditi Satti, MD; Kartik Shenoy, MD; Robert M. Steiner, MD; Alex Swift, MD; Irene Swift, MD; Maria Elena Vega-Sanchez, MD.<i>University of Alabama, Birmingham, AL:</i> Mark Dransfield, MD; William Bailey, MD; Surya P. Bhatt, MD; Anand Iyer, MD; Hrudaya Nath, MD; J. Michael Wells, MD.<i>University of California, San Diego, CA</i>: Douglas Conrad, MD; Xavier Soler, MD, PhD; Andrew Yen, MD.<i>University of Iowa, Iowa City, IA</i>: Alejandro P. Comellas, MD; Karin F. Hoth, PhD; John Newell, Jr., MD; Brad Thompson, MD.<i>University of Michigan, Ann Arbor, MI:</i> MeiLan K. Han, MD MS; Ella Kazerooni, MD MS; Wassim Labaki, MD MS; Craig Galban, PhD; Dharshan Vummidi, MD.<i>University of Minnesota, Minneapolis, MN</i>: Joanne Billings, MD; Abbie Begnaud, MD; Tadashi Allen, MD.<i>University of Pittsburgh, Pittsburgh, PA</i>: Frank Sciurba, MD; Jessica Bon, MD; Divay Chandra, MD, MSc; Joel Weissfeld, MD, MPH.<i>University of Texas Health, San Antonio, San Antonio, TX</i>: Antonio Anzueto, MD; Sandra Adams, MD; Diego Maselli-Caceres, MD; Mario E. Ruiz, MD; Harjinder Singh.
: Not applicable.
: KV has nothing to disclose. ND has nothing to disclose. IG receives personal funding from Research Foundation Flanders (FWO). MT is CEO and co-founder of ArtiQ but received no payments related to the manuscript. TT has nothing to disclose. JDC received funding from NIH Grant Support R01-089897 and is chairman of the COPD Foundation Board of Directors. EKS received funding from NIH Grant Support and institutional grant support from GlaxoSmithKline and Bayer. BJM received funding from NHLBI, grants from AstraZeneca, GlaxoSmithKline and Pearl Research and fees from AstraZeneca, GlaxoSmithKline, Sunovion, Verona, Boehringer Ingelheim, Takeda, Third Pole, Phillips and Circasia. He is member of the NHLBI and Spiration Data Safety Monitoring Boards and chairman of Mt. Sinai SOM Data Safety Monitoring Board. ER received a COPDGene grant from NHBLI. RJ received consulting fees from National Jewish Health for an LLC he owns. MDV received funding from the AI in Flanders project. WJ received grants from AstraZeneca and Chiesi and obtained fees from AstraZeneca, Chiesi and GlaxoSmithKline. He is chairman of Board of Flemish Society for TBC prevention and board member of ArtiQ.